Navigation Links
Vida Cannabis Allies with Florida Medical Cannabis Leader AltMed to Build Best-in-Class Expertise
Date:9/22/2014

Ottawa, ON (PRWEB) September 23, 2014

Vida Cannabis Corp. is pleased to announce the signing of a Strategic Alliance Agreement with Florida-based AltMed LLC.

The two companies will collaborate on research, quality assurance, and technical expertise. They’ll also pool business development know-how to capitalize on complimentary strengths in their respective markets.

"We’re deeply impressed with the level of sophistication, and operational know-how designed into the Vida Cannabis team as they work toward building the most advanced medical marijuana facility in Canada," says David Wright CEO of AltMed. "We have a parallel commitment to excellence in Florida, and we’ve identified vital complementary strengths and best practices that will guarantee that both of our companies excel."

Headed by former pharmaceutical executives, AltMed is focused on the science of medical cannabis. AltMed is forging skill-building alliances to lead in the delivery of effective, safe and well-tolerated alternative medicines. AltMed’s ultimate goal is to help people live better lives.

"With a strong team coupled with complimentary values and a focus on rigorous quality assurance and research, AltMed shares both our scientific DNA and our commitment to patients," says Greg Wilson CEO of Vida Cannabis.

Vida Cannabis has assembled outstanding production, quality control and research talents to pursue its vision of becoming Canada’s preeminent cannabis products innovator. The company has worldwide connections to the best production expertise in established markets including the Netherlands.

AltMed and Vida Cannabis are committed to science, compassion and community in their respective markets.

About Vida Cannabis: Vida Cannabis Corp. is working to develop uniquely high quality products to meet customer needs in the growing global marketplace for legal cannabis-based products. Initial operations are centered on the Canadian market, where the Federal Government has established national guidelines enabling best-in-class producers to acquire commercial production licenses for medicinal purposes. Vida has assembled one of the top management teams in the world, and has extensive access to expertise and resources in the United States, Canada and Europe. Its 315,000-square-foot production facility, located in Stellarton, Nova Scotia will be one of the largest, most advanced medical marijuana facilities in Canada.

About AltMed: AltMed LLC is a fully integrated, science-based Florida company dedicated to striving for compassion, community engagement and pharmaceutical industry precision in the development, production and dispensing of medical cannabis. Established in early 2014 by a consortium of Sarasota residents, AltMed's Executive Chairman and its CEO earned impressive credentials as top pharmaceutical executives. AltMed is participating in a competitive process with the intention of becoming one of five Florida licensees selected to grow and dispense medical cannabis under the Compassionate Medical Cannabis Act of 2014. For more information please visit AltMed.co.

Read the full story at http://www.prweb.com/releases/2014/09/prweb12185045.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Book Banning: The Illinois Department of Corrections Bans The Cannabis Papers by “Publius”
2. Added benefit of Cannabis sativa for spasticity due to multiple sclerosis is not proven
3. A risk gene for cannabis psychosis
4. Young adults more likely to smoke cannabis than drink before driving, 2011 CAMH Monitor survey shows
5. Cannabis use and the increased risk of psychosis: The debate continues
6. Medical cannabis provides dramatic relief for sufferers of chronic ailments
7. New D-I-Y Kit Allows Any Doctor To Recommend Medical Cannabis
8. CAMH study shows mental illness associated with heavy cannabis use
9. Exclusive Marijuana Industry Seminar To Be Held In Boston By Beantown's Own Cannabis Career Institute
10. Cannabis Career Institute Comes To Boston This Weekend
11. First Narconon Cannabis Abuse Prevention Guide Takes Aim at Drug Abuse Statistics for Italian Youth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2020)... ... ... Just found out your dear friend has cancer? , It’s hard to hear your doctor ... their diagnosis. Once the shock wears off, the questions and fears can be overwhelming. , ... ways to help? Words are failing me. I’m scared. I want to DO something. , ...
(Date:8/31/2020)... ... August 31, 2020 , ... Smile ... dental groups in the United States, today announced the grand opening of another ... , Patients will enjoy convenient hours, a comfortable office, and full-service care ...
(Date:8/31/2020)... ... 31, 2020 , ... Bonde Innovations, LLC, a venture-backed developer ... failure, today announced that the company has been awarded a Phase 1 Small ... Heart, Lung, and Blood Institute of the National Institutes of Health (NIH). The ...
(Date:8/28/2020)... ... 28, 2020 , ... With in-person gluten-free events being canceled ... the specialty-diet community connect with great, gluten-free brands. At the Online Nourished ... with brands & watch over 50 educational classes... all online from the comfort ...
(Date:8/27/2020)... LAS VEGAS (PRWEB) , ... August 27, 2020 ... ... open their doors! Sikara Medspa is a leading aesthetic and wellness retreat. The ... Summerlin area and surrounding areas of Las Vegas. , Designed to be ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... ... September 03, 2020 , ... Q&J Face Masks ... ), an aerosol and engineering lab, conducted tests on Q&J’s personal face mask ... virus than many other masks. Q&J face masks have both mechanical filtering and ...
(Date:9/2/2020)... , ... September 02, 2020 , ... U.S. Dermatology ... Lee . Dr. Lee will work at Bethesda Dermatopathology Lab. , ... B.A. from the University of California, Berkley. He went on to receive his M.D. ...
(Date:9/1/2020)... ... September 01, 2020 , ... Breast and ovarian cancers are ... (CDC), About 3% of breast cancers (about 7,500 women per year) and 10% of ... and BRCA2 genes. Both genes are detectable in the Women’s Excellence Genetic Testing ...
Breaking Medicine Technology: